4//SEC Filing
Grossi Federico 4
Accession 0001127602-22-005042
CIK 0001492422other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:59 PM ET
Size
6.5 KB
Accession
0001127602-22-005042
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-02-14−3,600→ 61,823 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (3,600 underlying) - Exercise/Conversion
Common Stock
2022-02-14$4.31/sh+3,600$15,516→ 106,461 total
Footnotes (1)
- [F1]This stock option was granted on 08/21/2017 and is fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:59 PM ET
- Size
- 6.5 KB